ϟ
DOI: 10.1093/annonc/mdy334
¤ OpenAccess: Hybrid
This work has “Hybrid” OA status. This means it is free under an open license in a toll-access journal.
PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers
Joshua K. Sabari,Giulia C. Leonardi,Catherine A. Shu,Renato Umeton,Joseph Montecalvo,Ai Ni,R. Chen,Jordan Dienstag,Chebli Mrad,Isabella Bergagnini,W. Victoria Lai,Michael Offin,Kathryn C. Arbour,Andrew J. Plodkowski,Darragh Halpenny,Paul K. Paik,B.T. Li,Gregory J. Riely,Mark G. Kris,Charles M. Rudin,Lynette M. Sholl,Mizuki Nishino,Matthew D. Hellmann,Natasha Rekhtman,Mark M. Awad,Alexander Drilon
Medicine
Exon
Lung cancer
2018
Loading...
- MLA
- APA
- Chicago
- IEEE
- Harvard
- BibTeX
Cite this:
Generate Citation
“PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers” is a paper by Joshua K. Sabari Giulia C. Leonardi Catherine A. Shu Renato Umeton Joseph Montecalvo Ai Ni R. Chen Jordan Dienstag Chebli Mrad Isabella Bergagnini W. Victoria Lai Michael Offin Kathryn C. Arbour Andrew J. Plodkowski Darragh Halpenny Paul K. Paik B.T. Li Gregory J. Riely Mark G. Kris Charles M. Rudin Lynette M. Sholl Mizuki Nishino Matthew D. Hellmann Natasha Rekhtman Mark M. Awad Alexander Drilon published in 2018. It has an Open Access status of “hybrid”. You can read and download a PDF Full Text of this paper here.